Cargando…
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Cancer is a major health burden worldwide, and despite continuous advances in medical therapies, resistance to standard drugs and adverse effects still represent an important cause of therapeutic failure. There is a growing evidence that gut bacteria can affect the response to chemo- and immunothera...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964925/ https://www.ncbi.nlm.nih.gov/pubmed/29789015 http://dx.doi.org/10.1186/s40168-018-0483-7 |